Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pro Ox Bio AB
AB
Active
Org 5569657595
Önologgatan 1, 117 57
Stockholm
Diagnostic imaging services and medical laboratory activities
·
NACE 8691
Est. 2014 · 12 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Diagnostic imaging services and medical laboratory activities
/
Pro Ox Bio AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 1M (-50% vs 2024)
1M
-50%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 263
1 808
2 355
2 196
1 715
Staff expenses
−763
−735
−794
−849
—
EBITDA
204
743
1 228
1 105
737
Depreciation & amort.
—
—
−96
−96
−96
EBIT
204
743
1 132
1 009
641
Net financials
30
8
4
2
−22
Profit before tax
4
1
36
6
4
Tax
−1
−2
−10
−4
−2
Net profit
3
−1
26
1
2
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 205
3 908
3 584
2 458
2 298
Equity
313
310
311
285
283
Long-term debt
3 824
3 514
2 956
2 024
983
Short-term debt
68
84
317
149
871
Total debt
3 892
3 598
3 273
2 173
1 854
Financial ratios
5-year trend
EBITDA margin
16,2 %
This company
15,8 %
Market median
This company
Market median
3% above market
2021
2025
Equity ratio
7,4 %
This company
38,2 %
Market median
This company
Market median
81% below market
2021
2025
Return on equity
1,0 %
This company
18,4 %
Market median
This company
Market median
95% below market
2021
2025
Net profit margin
0,3 %
This company
8,1 %
Market median
This company
Market median
96% below market
2021
2025
Asset turnover
0,30×
This company
1,12×
Market median
This company
Market median
73% below market
2021
2025
Debt / equity
12,44×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Pro Ox Bio AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
